We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.

Key Record Dates

ClinicalTrials.gov Identifier: NCT05011058
Brief Title: An Open-Label, Phase 2 Trial of Nanatinostat in Combination With Valganciclovir in Patients With Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas (NAVAL-1)

First Submitted : August 2, 2021
First Submitted that Met QC Criteria : August 11, 2021
First Posted : August 18, 2021

Last Update Submitted that Met QC Criteria : March 30, 2023
Last Update Posted : April 3, 2023